搜索
Neuronetics Inc
STIM添加自选
1.860USD
-0.020-1.06%
收盘 07-23 16:00（美东）报价延迟15分钟
129.42M总市值
亏损市盈率 TTM
关于 Neuronetics Inc 公司
Neuronetics, Inc. a vertically integrated, commercial stage, medical technology and healthcare company. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The Company provides more than 7.1 million treatments to over 1,95,000 patients.
Neuronetics Inc简介
公司代码STIM
公司名称Neuronetics Inc
上市日期Jun 28, 2018
CEOMr. Keith J. Sullivan
员工数量716
证券类型Ordinary Share
年结日Jun 28
公司地址3222 Phoenixville Pike
城市MALVERN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编19355
电话18776007555
网址https://neurostar.com/neuronetics/
公司代码STIM
上市日期Jun 28, 2018
CEOMr. Keith J. Sullivan
Neuronetics Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Sasha Cucuz
Mr. Sasha Cucuz
Director
Director
2.06M
+1.46%
Mr. Steven Pfanstiel
Mr. Steven Pfanstiel
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
828.78K
+1.03%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
625.02K
+5.80%
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
340.45K
+8.81%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
190.35K
+15.76%
Ms. Megan Rosengarten
Ms. Megan Rosengarten
Independent Director
Independent Director
170.89K
+17.56%
Mr. Mark Klausner
Mr. Mark Klausner
Managing Partner
Managing Partner
--
--
Mr. W. Andrew Macan
Mr. W. Andrew Macan
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
--
--
Dr. Avinash N. Amin, M.D.
Dr. Avinash N. Amin, M.D.
Director
Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Sasha Cucuz
Mr. Sasha Cucuz
Director
Director
2.06M
+1.46%
Mr. Steven Pfanstiel
Mr. Steven Pfanstiel
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
828.78K
+1.03%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
625.02K
+5.80%
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
340.45K
+8.81%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
190.35K
+15.76%
Ms. Megan Rosengarten
Ms. Megan Rosengarten
Independent Director
Independent Director
170.89K
+17.56%
常见问题
Neuronetics Inc的前五大股东是谁？
Neuronetics Inc 的前五大股东如下：Mr. Sasha Cucuz
有多少机构持有Neuronetics Inc(STIM)的股份？
截至2026Q1，共有236家机构持有Neuronetics Inc的股份，合计持有的股份价值约为47.87M，占公司总股份的68.80%。与2025Q4相比，机构持股有所增加，增幅为-7188276.00。
哪个业务部门对Neuronetics Inc的收入贡献最大？
在2026Q1，Clinic revenue业务部门对Neuronetics Inc的收入贡献最大，创收86.98M，占总收入的58.31%。